We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+24.81%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$18.7B
AUM Growth
+$4.8B
(+35%)
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
1,702
New
548
Increased
855
Reduced
264
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$140M |
| 2 |
Microsoft
MSFT
|
+$124M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
Carrier Global
CARR
|
+$94.7M |
| 5 |
Otis Worldwide
OTIS
|
+$88.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$47.8M |
| 2 |
Abbott
ABT
|
+$25.1M |
| 3 |
Colgate-Palmolive
CL
|
+$24.3M |
| 4 |
Hormel Foods
HRL
|
+$23.2M |
| 5 |
Walmart Inc
WMT
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.9% |
| 2 | Consumer Discretionary | 13.41% |
| 3 | Industrials | 11.79% |
| 4 | Financials | 10.2% |
| 5 | Healthcare | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Innospec
IOSP
$2.09B
| $289K | ﹤0.01% |
+3,737
| New | +$273K |
|
1252
Amphastar Pharmaceuticals
AMPH
$825M
| $287K | ﹤0.01% |
+12,769
| New | +$234K |
|
1253
Sally Beauty Holdings
SBH
$1.4B
| $287K | ﹤0.01% |
22,893
+11,697
| +104% | +$128K |
|
1254
NewMarket
NEU
$7.17B
| $285K | ﹤0.01% |
+712
| New | +$294K |
|
1255
MillerKnoll
MLKN
$1.5B
| $284K | ﹤0.01% |
+12,041
| New | +$272K |
|
1256
Shake Shack
SHAK
$2.3B
| $284K | ﹤0.01% |
+5,357
| New | +$271K |
|
|
MANT
1257
DELISTED
Mantech International Corp
MANT
| $284K | ﹤0.01% |
+4,145
| New | +$305K |
|
1258
Simmons First National
SFNC
$3.35B
| $283K | ﹤0.01% |
+16,537
| New | +$283K |
|
1259
Belden
BDC
$4B
| $282K | ﹤0.01% |
+8,665
| New | +$288K |
|
1260
ManpowerGroup
MAN
$2.39B
| $281K | ﹤0.01% |
+4,089
| New | +$279K |
|
1261
Match Group
MTCH
$8.84B
| $281K | ﹤0.01% |
+2,629
| New | +$220K |
|
1262
Rocket Pharmaceuticals
RCKT
$348M
| $281K | ﹤0.01% |
+13,443
| New | +$242K |
|
1263
Atara Biotherapeutics
ATRA
$71.2M
| $280K | ﹤0.01% |
770
+352
| +84% | +$88.9K |
|
|
AIMT
1264
DELISTED
Aimmune Therapeutics
AIMT
| $280K | ﹤0.01% |
16,746
+5,404
| +48% | +$91.8K |
|
1265
Workiva
WK
$2.94B
| $279K | ﹤0.01% |
+5,221
| New | +$214K |
|
|
AIMC
1266
DELISTED
Altra Industrial Motion Corp
AIMC
| $279K | ﹤0.01% |
+8,767
| New | +$232K |
|
|
PPBI
1267
DELISTED
Pacific Premier Bancorp
PPBI
| $278K | ﹤0.01% |
+12,813
| New | +$257K |
|
|
NGM
1268
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $278K | ﹤0.01% |
14,081
+3,470
| +33% | +$66.3K |
|
1269
Monro
MNRO
$525M
| $277K | ﹤0.01% |
+5,041
| New | +$268K |
|
|
UNIT
1270
Uniti Group
UNIT
$2.63B
| $277K | ﹤0.01% |
29,647
+15,559
| +110% | +$117K |
|
|
MDC
1271
DELISTED
M.D.C. Holdings, Inc.
MDC
| $277K | ﹤0.01% |
+8,375
| New | +$231K |
|
1272
Albany International
AIN
$2.14B
| $276K | ﹤0.01% |
+4,693
| New | +$254K |
|
1273
Dorman Products
DORM
$4.01B
| $275K | ﹤0.01% |
+4,104
| New | +$264K |
|
1274
Wyndham Hotels & Resorts
WH
$5.46B
| $275K | ﹤0.01% |
+6,463
| New | +$264K |
|
|
UFS
1275
DELISTED
DOMTAR CORPORATION (New)
UFS
| $275K | ﹤0.01% |
+13,011
| New | +$282K |
|
Similar funds
ProShare Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, ProShare Advisors held 1,702 positions worth $18.7B, up 35% from $13.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
ProShare Advisors deployed $1.69B of net new capital in Q2 2020, opening 548 new positions and adding to 855 existing holdings. Its largest new stake was Carrier Global: 5,097,223 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Clorox, an estimated $47.8M trimmed.
- ProShare Advisors's largest Q2 2020 buy was Carrier Global: 5,097,223 shares worth $113M.
- ProShare Advisors added most to Amazon in Q2 2020, an estimated $140M increase.
- ProShare Advisors's biggest Q2 2020 reduction was Clorox, cutting an estimated $47.8M.
- ProShare Advisors fully exited Utah Medical Products in Q2 2020, selling an estimated $11.6M.
- ProShare Advisors's ten largest holdings make up 24% of its $18.7B portfolio in Q2 2020.
- ProShare Advisors opened 548 new positions and closed 34 in Q2 2020.
- ProShare Advisors's portfolio value rose 35% quarter-over-quarter to $18.7B.
Based on ProShare Advisors's 13F filing for Q2 2020, filed 3 Aug 2020.